# DifGen Pharmaceuticals Announces First Major European Milestone with Successful Completion of Decentralised Procedure for Tafamidis 61 mg Capsules

- Source: PR Newswire
- Published: 2026-10-27T19:18:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/difgen-pharmaceuticals-announces-first-major-european-milestone-with-successful-completion-of-decentralised-procedure-for-tafamidis-61-mg-capsules-302921167.html
- Canonical: https://groundlevelnews.com/story/difgen-pharmaceuticals-announces-first-major-european-milestone-with-s-0f921c/

Significant regulatory achievement marks an important step in DifGen's European expansion and strengthens its foundation for strategic partnerships MIRAMAR, Fla., Oct. 27, 2026 /PRNewswire/ -- DifGen Pharmaceuticals LLC ("DifGen"), a U.S.-based pharmaceutical company focused on the...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire._